Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.46 USD | -4.04% | -5.38% | -42.02% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.02% | 781M | |
+3.36% | 106B | |
+7.02% | 23.47B | |
-14.85% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.21% | 16.78B | |
+6.40% | 14.41B | |
+34.88% | 12.86B | |
+315.31% | 8.78B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Biogen Inc., Sage Therapeutics, Inc. - Special Call